Trial intelligence / Profile preview

Valsartan versus valsartan + hydrochlorothiazide for mild to moderate arterial hypertension

2012-005129-57Phase 4Completed

Sponsor
Krka
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan, valsartan + hydrochlorothiazide in essential hypertension, hypertension (HTN), sponsored by Krka. Started Jan 2013; status: completed.

02

Drugs

valsartanvalsartan + hydrochlorothiazide
03

Conditions

essential hypertensionhypertension (HTN)

Beyond the preview

Go deeper on 2012-005129-57.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005129-57.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call